2017 AAM Biosimilars Council Conference
September 13, 2017

Axinn partner Stacie Ropka presented "Biosimilars at the Bar: Legal Issues," at Leading on Biosimilars: The 2017 AAM Biosimilars Council Conference in Washington, DC. Presented by the Association for Accessible Medicines and its Biosimilars Council, this interactive conference provided attendees with the opportunity to learn the most up-to-date information regarding regulatory, reimbursement, legal, political, and policy environments surrounding access to biosimilar products. A key focus of this conference was sessions dedicated to educating the public, the patients, and the health care professionals, about the safety and effectiveness of biosimilars.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.